2010
DOI: 10.1016/j.ad.2009.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Mucinosis eritematosa reticular: respuesta parcial al tratamiento con tacrolimus tópico

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0
7

Year Published

2010
2010
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 9 publications
0
4
0
7
Order By: Relevance
“…Hydroxychloroquine, a derivative of chloroquine, is frequently used as the first-line treatment, and it always results in rapid improvement within about a month of starting the treatment; however, recurrence is also common5. The present patient responded well to hydroxychloroquine.…”
mentioning
confidence: 57%
See 3 more Smart Citations
“…Hydroxychloroquine, a derivative of chloroquine, is frequently used as the first-line treatment, and it always results in rapid improvement within about a month of starting the treatment; however, recurrence is also common5. The present patient responded well to hydroxychloroquine.…”
mentioning
confidence: 57%
“…REM, first described by Steigleder, is a rare cutaneous disease, characterized by persistent erythema in a reticular pattern and/or confluent erythematous papules and plaques, with a predilection of location on the central area of the chest or on the upper back; and rarely on the arms, face and abdominal region3-5. It predominantly afflicts middle-aged women3-5.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Afecta a personas de todas las edades y de ambos sexos, pero predomina en las mujeres jóvenes o de mediana edad [4][5][6] .…”
Section: Comentariosunclassified